Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Margaret M. Fitzpatrick currently holds 10,708 shares of Vistagen Therapeutics, Inc. (VTGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Margaret M. Fitzpatrick has been a net buyer of VTGN stock. They have purchased $11.6K and sold $0 worth of shares.
Margaret M. Fitzpatrick's most recent insider trade was on Sep 1, 2026, when they purchased 2,098 shares at $5.53 per share.
Margaret M. Fitzpatrick serves as Executive at Vistagen Therapeutics, Inc. (VTGN). They have executed 4 insider transactions totaling $11.6K over their tenure at the company.
Margaret M. Fitzpatrick holds the position of Executive at Vistagen Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Margaret M. Fitzpatrick has shown a buying trading pattern, with $11.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Margaret M. Fitzpatrick was on Sep 1, 2026, when they purchased $11.6K worth of ANTX shares. This transaction involved 2,098 shares at $5.53 per share.
Margaret M. Fitzpatrick currently owns 10,708 shares of Vistagen Therapeutics, Inc. (VTGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Margaret M. Fitzpatrick's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Margaret M. Fitzpatrick has 4 Form 4 filings on record as an insider at Vistagen Therapeutics, Inc..
Set alerts for Margaret M. Fitzpatrick and 40,000+ other insiders.